Literature DB >> 22007540

[Screening of plant pathogenic fungi by ginsenoside compound K production].

Yuanchao Yang1, Yingping Wang, Meixia Yan, Chenghe Sun, Peihe Zheng.   

Abstract

OBJECTIVE: To screen a new strain which can transform panaxadiol saponins into the rare ginsenoside compound K.
METHOD: The total saponins in stems and leaves of Panax notoginseng was used as a substrate in the liquid state fermentation process, and the results were detected by TLC and HPLC-ELSD to screen a strain from twelve plant pathogenic fungi which can produce ginsenoside compound K. RESULT: Fusarium moniliforme was found to transform the total saponins to ginsenoside compound K efficiently in the all twelve fungal strains. In the fermentation process, ginsenoside Rb1 was transformed almost completely, and the content of ginsenoside Rd was decreasing evidently.
CONCLUSION: F. moniliforme is selected as a new high-yield strain. It is expected to be used to produce the high activity infrequent ginsenoside compound K and to improve the content of active principles in medicinal plants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22007540

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

Review 1.  Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis.

Authors:  Jinlong Liu; Yuchen Wang; Zhun Yu; Guangfu Lv; Xiaowei Huang; He Lin; Chao Ma; Zhe Lin; Peng Qu
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.077

Review 2.  A narrative review of the pharmacology of ginsenoside compound K.

Authors:  Tao Liu; Lu Zhu; Li Wang
Journal:  Ann Transl Med       Date:  2022-02

Review 3.  Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations.

Authors:  Mohanapriya Murugesan; Ramya Mathiyalagan; Vinothini Boopathi; Byoung Man Kong; Sung-Keun Choi; Chang-Soon Lee; Deok Chun Yang; Se Chan Kang; Thavasyappan Thambi
Journal:  Nanomaterials (Basel)       Date:  2022-09-30       Impact factor: 5.719

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.